Based on PubMed | Does smoking increase the risk of developing Hashimoto's thyroiditis?

Smoking does not appear to raise the long‑term risk of developing Hashimoto’s thyroiditis (autoimmune hypothyroidism), and some large population studies suggest current smokers have a lower prevalence of thyroid autoantibodies and autoimmune hypothyroidism compared with non‑smokers. ^[1] However, there is a notable and temporary increase in the diagnosis of overt autoimmune hypothyroidism during the first 1–2 years after quitting smoking. ^[2]

What research shows

• Current smoking and antibodies: In population surveys, people who currently smoke tend to have slightly lower rates of thyroid peroxidase and thyroglobulin antibodies, and a lower risk of subclinical and overt autoimmune hypothyroidism, with a dose‑response pattern; this reduced risk disappears within about three years after cessation. ^[1]
• After quitting: A population‑based case‑control study (over 2 million person‑years monitored) found the odds of newly diagnosed overt autoimmune hypothyroidism were more than sixfold higher in the first two years after smoking cessation compared with never‑smokers, then returned to baseline thereafter. ^[2]

Why this pattern might happen

• Nicotine’s immune effects: Experimental and epidemiologic data suggest nicotine can have anti‑inflammatory effects that might blunt thyroid autoimmunity while a person is actively smoking. ^[1]
• Rebound after cessation: When smoking stops, this immunomodulatory effect likely wanes, and autoantibody levels can rise transiently, which may unmask or accelerate detection of hypothyroidism in the first 1–2 years after quitting. ^{[2] [1]}

Important nuance

• Overall risk perspective: While current smoking does not seem to increase and may temporarily lower the measured risk of autoimmune hypothyroidism, this does not mean smoking is protective in a meaningful health sense; smoking causes substantial harm across nearly every organ system. ^[1]
• Other thyroid conditions: Smoking is a clear risk factor for Graves’ disease and especially thyroid eye disease (Graves’ ophthalmopathy), and it worsens outcomes in these conditions. ^[1]

Practical takeaways for people who smoke or recently quit

• Don’t use smoking to “prevent” Hashimoto’s: The overall health risks of smoking far outweigh any observed association with lower autoantibody rates. ^[1]
• If you recently quit: It may be reasonable to have a low threshold for checking thyroid function (TSH and free T4) if symptoms such as fatigue, cold intolerance, constipation, dry skin, hair loss, or menstrual changes appear within the first 1–2 years after cessation, given the transiently higher incidence window described in population data. ^[2]
• Long‑term outlook: The elevated risk period after quitting appears time‑limited, with risk returning to that of never‑smokers after roughly two years and the “lower risk” seen in current smokers disappearing within about three years of cessation. ^{[2] [1]}

Bottom line

• Based on current evidence, smoking does not increase the long‑term risk of Hashimoto’s thyroiditis; if anything, current smoking is associated with lower autoantibody prevalence and lower measured risk of autoimmune hypothyroidism, likely via nicotine’s anti‑inflammatory effects. ^[1]
• After quitting, there is a short‑term spike in overt autoimmune hypothyroidism diagnoses (first 1–2 years), which then subsides, so awareness and symptom‑based testing during this period can be helpful. ^[2]
• Quitting smoking remains strongly recommended for overall health, despite these thyroid‑specific associations. ^[1]

---

Quick comparison at a glance

Scenario	Autoimmune hypothyroidism (Hashimoto’s) risk	Thyroid autoantibodies	Notes
Current smoking	Lower risk vs non‑smokers (dose‑dependent)	Lower prevalence	Effect likely mediated by nicotine’s anti‑inflammatory properties; not a reason to smoke. [1]
0–2 years after quitting	Markedly higher odds of overt hypothyroidism diagnosis	Antibodies may rise	Transient window; consider testing if symptomatic. [2]
>2–3 years after quitting	Returns to baseline (similar to never‑smokers)	“Smoker effect” disappears	Long‑term benefits of cessation dominate. [2] [1]